Related Experiment Video
Updated: Feb 7, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
Published on: May 13, 2022
Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration
Elaine J Abrams1, Jintanat Ananworanich2,3,4, Moherndran Archary5
1ICAP at Columbia, Mailman School of Public Health, College of Physicians & Surgeons, Columbia University, New York, NY.
Insights
Accelerating pediatric HIV treatment requires overcoming developmental and regulatory hurdles. Innovations in diagnosis and treatment, supported by basic science and global collaboration, are crucial for an AIDS-free generation.
Area of Science:
- Pediatric infectious diseases
- HIV/AIDS therapeutics
- Global health initiatives
Background:
- Significant delays exist in developing new HIV medications and treatments for children.
- Obstacles include physiological changes during childhood and complex regulatory environments.
Purpose of the Study:
- To summarize current and emerging initiatives for accelerating the pediatric HIV therapeutic agenda.
- To highlight innovations in diagnosis and treatment for young children with HIV.
Main Methods:
- Review of global initiatives and case studies.
- Focus on innovations in diagnosis and treatment for pediatric HIV.
- Emphasis on basic science research and study design.
Main Results:
- Challenges in pediatric HIV research stem from developmental changes and regulatory complexities.
- Efforts to accelerate progress include prioritizing treatments, weight-based dosing, innovative study designs, and global research networks.
- Case studies demonstrate the impact of basic science and novel approaches in diagnosing and treating infants.
Conclusions:
- An accelerated pediatric therapeutic agenda is vital for achieving an AIDS-free generation.
- This agenda must be informed by basic science, driven by innovation, and fostered through global cooperation.
Background:
A number of well-described obstacles to the pediatric therapeutic agenda have resulted in substantial delays in the introduction of new medications, formulations, strategies, and approaches to treat infants, children, and adolescents living with HIV.
Setting:
Global landscape.
Methods:
The authors will provide a summary of current and emerging initiatives to accelerate the pediatric therapeutic agenda including illustrative case studies of innovations and scientific discovery in diagnosis and treatment of very young children with HIV infection.
Results:
The challenges posed by rapid physiologic and developmental changes that characterize the trajectory of childhood as well as the complex regulatory and fiscal milieu of HIV therapeutics have hampered pediatric HIV therapeutic research. Recent efforts to accelerate this agenda include prioritizing agents and formulations, defining dosing by weight bands, applying innovative study designs, synergizing work across research networks to achieve common goals, and the establishment of a global prioritized research agenda. A case study of initiatives to diagnose and effectively treat newborns and infants will illustrate the critical role of basic science research and novel approaches to study design and implementation that are informing global efforts to end AIDS.
Conclusions:
A pediatric therapeutic agenda informed by basic science and achieved through innovation and global cooperation is essential to achieve an AIDS-free generation.
Related Concept Videos
Psychology as a Science
The scientific method in psychology involves six critical steps: making observations, formulating hypotheses, conducting tests, analyzing...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Overview of Biostatistics in Health Sciences
Therapeutic Index
Statistical Package for the Social Sciences (SPSS)
SPSS streamlines the process from data preparation to analysis and reporting. It is characterized by its user-friendly interface, which conceals...
Pharmacokinetics in Pediatric Patients: Drug Excretion

